EIT Digital Innovation Activity 'ki elements' Showcases its First Prototype: DELTA

EIT DigitalThe EIT Digital Innovation Activity 'ki elements' showcases its first prototype called DELTA in Nice at the Institut Claude Pompidou on Innovation Alzheimer Open Day.

In the beginning of 2017, EIT Digital launched ELEMENT, a new Innovation Activity to facilitate faster, earlier diagnosis and intervention for cognitive decline.

In June 2017, the Innovation Activity ELEMENT took a new step forward with the official launch of its start-up: ki elements.

CEO Jan Alexandersson (also Activity Lead) of ELEMENT explains: "We are very proud and happy to showcase our first prototype called Delta during the Innovation Alzheimer Day in collaboration with Association Innovation Alzheimer at the Institut Claude Pompidou in Nice. Our prototype is an iPad app for psychometric testing based on language as diagnosis support for professionals working in psychiatry, neuropsychology and speech pathology."

How the Delta app works:

  • Delta records and saves speech data and synchronises it with your HIS (Hospital Information System). This allows you to easily re-listen to patients and empowers your professional decisions.
  • Delta automatically transcribes answers from cognitive speech tests to keep your attention free for the most important thing: your work with the patient.
  • Delta leverages AI and computational linguistics to extract and analyse powerful scientific metrics from patients' answers.
  • Delta gives you comprehensive insight by visualising the extracted metrics. Combined with population cut-off values, this visualisation helps to enrich your professional impression
  • Delta compiles your test analysis, visualisations and your interpretation/diagnosis into a digital report formatted to your clinic's guidelines.

Jan Alexandersson continues: "We are hoping this prototype demo will help us find our potential first customers, collect feedback about our value proposition. We are also working on CE certification of our product and looking to extending our portfolio towards the German market by the end of 2018. For 2017, our focus is on the French market."

The mission of ki elements is to provide health professionals with AI-empowered tools as key elements to excel in their profession.

ELEMENT has implemented a first alpha version of the product targeting dementia diagnosis support for clinicians based on speech analysis.

Dementia is a cognitive disorder, mainly caused by neurodegenerative diseases, such as Alzheimer's disease but also strokes, which leads to a loss of autonomy and is associated with significant decrease in quality of life. In 2015 around the world, there were 9.9 million new cases of dementia: one every 3 seconds*. This number is expected to double every 20 years and reach 68% of the worldwide population in 2050 (mostly in low-medium income countries and due, in part, to fewer births and a growing elderly population).

Partners involved in the Innovation Activity are:

  • DFKI: Activity lead, coordination, mobile and app integration
  • ki elements (sub-grantee of DFKI GmbH): commercialisation of project results
  • Inria: Corpus collection, video analysis and clinical trials
  • University of Edinburgh: Trials and validation of current system for British English
  • Innovation Alzheimer (sub-grantee of INRIA): Clinical partner providing access to dementia patients for French corpus collection and tests. Clinical personnel will be involved.

    * Alzheimer's Disease International

    About EIT Digital
    EIT Digital seeks to generate significant innovations from top European research. As such, we focus our investments on a limited number of innovation areas known as Innovation Action Lines, that we have selected with respect to their European relevance and leadership potential. Each Innovation Action Line comprises a portfolio of activities including:

    • open innovation activities carried out by the EIT Digital Partners and
    • fast-growing technology startups that are ready to scale commercially.

    Our Innovation Activities deliver new products or services, create startups and spinoffs to commercialise outputs from projects and encourage the transfer of technologies for market entry.

  • Most Popular Now

    Research Shows AI Technology Improves Pa…

    Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

    Who's to Blame When AI Makes a Medi…

    Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

    First Therapy Chatbot Trial Shows AI can…

    Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

    DMEA sparks: The Future of Digital Healt…

    8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

    DeepSeek: The "Watson" to Doct…

    DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

    Stepping Hill Hospital Announced as SPAR…

    Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

    DMEA 2025: Digital Health Worldwide in B…

    8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...